Immunicum submits a new patent application, EP12197687.2, to protect a process for mass production of INTUVAC and SUBCUVAC.
Immunicum participates and is presented at Bio-Europe 2012, in Hamburg, Germany.
Immunicum is presented at Seed Forum in Stockholm.
Immunicum participates in, and is presented at, BioPartnering Future Europe i Brussels, Belgium.
Immunicum vaccine INTUVAC is mentioned in Thomson Reuters’ “A Pharma Matters Report: THE ONES TO WATCH” as one… Read more
Immunicum is featured in an insert to Dagens Industri. Read the article here.
Immunicum’s CEO, Jamal El-Mosleh, holds a company presentation at “China Sweden Life Science Forum” in Stockholm, Sweden.
Immunicum is presented in BiotechSweden. Read the article here.